How is Agile PLM Compliant with FDA Part 11.200(a)(3)
(Doc ID 2580506.1)
Last updated on JANUARY 24, 2024
Applies to:
Oracle Agile PLM Framework - Version 9.3.6.0 and laterInformation in this document applies to any platform.
Goal
How is Agile PLM compliant with FDA Part 11.200(a)(3)?
FDA Part 11.200(a)(3) is stated as below:
Sec. 11.200 Electronic signature components and controls.
(a) Electronic signatures that are not based upon biometrics shall:
(3) Be administered and executed to ensure that attempted use of an individual's electronic signature by anyone other than its genuine owner
requires collaboration of two or more individuals.
Ref: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=11.200
Solution
To view full details, sign in with your My Oracle Support account. |
|
Don't have a My Oracle Support account? Click to get started! |
In this Document
Goal |
Solution |
References |